PRCTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
PROCEPT BioRobotics Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$18.28+0.71 (+4.04%)
Close on Oct 19, 2026
- Market cap
- $1.04B
- P/E (TTM)
- –
- Dividend yield
- –
PROCEPT BioRobotics Corp revenue by segment
By business segment
By product or service
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| United States | $270.38M | $200.47M | $124.30M | $67.77M | $28.95M | $4.10M | 87.8% | +34.9% |
| Outside the United States | $37.68M | $24.03M | $11.89M | – | – | – | 12.2% | +56.8% |
| Outside of U.S. | – | $24.03M | $11.89M | $7.25M | $5.53M | $3.62M | – | – |
From the segment and revenue-disaggregation notes of PROCEPT BioRobotics's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.